Home › Hereditary Sensory and Autonomic Neuropathies › NCT03920774
The Natural History of Familial Dysautonomia
Natural History of Familial Dysautonomia
Who can join
Ages 4 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * Patients of any age with a diagnosis of familial dysautonomia (FD) with molecular confirmation of the IKBKAP mutation. * Ability to provide informed consent (or assent) and comply with the study protocol Exclusion Criteria: * Subjects that do not wish to be a part of the study.
About the study
The study will collect clinical information from patients with FD and allow them to give blood to help develop biological markers of the disease to aid diagnosis and treatment.
This is a non-invasive, non-interventional, observation study that poses only minimal risk for participants. The study will document the clinical features of patients with FD overtime by storing their routine clinical test results in a central database. The study will involve collaborators at other specialist clinics around the world who follow/evaluate patients with FD annually. Providing blood for future use is optional.
Sponsor: NYU Langone Health · Participants: 400 · Started: Feb 22, 2017
Contact the study team
- Britney A. Paredes Lopez · Phone: 2122637225
Official record on ClinicalTrials.gov — NCT03920774
Locations in the U.S.
| New York | Dysautonomia Center - School of Medicine -NYU Langone Medical Center, New York |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.